5061972025-07-012025-09-305061972025-09-305061972025-03-315061972025-04-012025-09-305061972025-07-012025-09-30in-capmkt:OtherExpenses1Member5061972025-07-012025-09-30in-capmkt:OtherExpenses2Member5061972025-07-012025-09-30in-capmkt:OtherExpenses3Member5061972025-07-012025-09-30in-capmkt:OtherExpenses4Member5061972025-07-012025-09-30in-capmkt:OtherExpenses5Member5061972025-07-012025-09-30in-capmkt:OtherExpenses6Member5061972025-07-012025-09-30in-capmkt:OtherExpenses7Member5061972025-07-012025-09-30in-capmkt:OtherExpenses8Member5061972025-07-012025-09-30in-capmkt:OtherExpenses9Member5061972025-07-012025-09-30in-capmkt:OtherExpenses10Member5061972025-04-012025-09-30in-capmkt:OtherExpenses1Member5061972025-04-012025-09-30in-capmkt:OtherExpenses2Member5061972025-04-012025-09-30in-capmkt:OtherExpenses3Member5061972025-04-012025-09-30in-capmkt:OtherExpenses4Member5061972025-04-012025-09-30in-capmkt:OtherExpenses5Member5061972025-04-012025-09-30in-capmkt:OtherExpenses6Member5061972025-04-012025-09-30in-capmkt:OtherExpenses7Member5061972025-04-012025-09-30in-capmkt:OtherExpenses8Member5061972025-04-012025-09-30in-capmkt:OtherExpenses9Member5061972025-04-012025-09-30in-capmkt:OtherExpenses10Member5061972025-07-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15061972025-07-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25061972025-04-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15061972025-04-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25061972025-07-012025-09-30ItemsThatWillBeReclassifiedToProfitAndLoss15061972025-07-012025-09-30ItemsThatWillBeReclassifiedToProfitAndLoss25061972025-04-012025-09-30ItemsThatWillBeReclassifiedToProfitAndLoss15061972025-04-012025-09-30ItemsThatWillBeReclassifiedToProfitAndLoss2iso4217:INRiso4217:INRxbrli:shares506197BLISSGVSNOTLISTEDINE416D01022Bliss GVS Pharma LimitedMain BoardEquity2025-04-012026-03-312025-11-062025-10-29INRLakhsQuarterlySecond quarterSingle segmentPharmaceuticals2025-11-0616:30:002025-11-0618:10:00trueCash Flow IndirectNot applicable2025-07-012025-09-30UnauditedConsolidated2443985000201780000264576500095368200022646000204192000333513000304180008261700061237000022394380004063270000406327000143105000-2266400012044100002858860000000285886000-4981200023607400027250400013382000-49811500010564900012.582.54002.582.542025-04-012025-09-30UnauditedConsolidated451867700059161100051102880001887805000228393000-167630006435390008513300016463000010801150004072852000103743600001037436000348054000-40117000307937000072949900000007294990008709000738208000702883000266160008709500010564900016.666.58006.666.58Freight outward94436000ECL expenses110953000Travelling and Conveyance expenses17765000Repairs and Maintenance56309000Power and Fuel36136000Business Development expenses88442000Corporate Social Responsibility expenses10085000Sales Promotion expenses20115000Legal and Professional Charges20730000Others157399000Freight outward166276000ECL expenses133391000Travelling and Conveyance expenses31353000Repairs and Maintenance99775000Power and Fuel64154000Business Development expenses206241000Corporate Social Responsibility expenses27342000Sales Promotion expenses35756000Legal and Professional Charges41211000Others274616000383448300039367800068210007711100022760004918300000411229000460412000490120002761130005099906000119002300050054000491089000029147200016647540002580004519470007369375000034169700089010950000014001001000105649000112177560001132340500035883000011682235000130405000170335000300740000209890000040400032213300022954400019620300075278800094899100050907500016876100007402900030160000204834000019966330000023187660001400100100085133000-55550000-5727550000-44702000-309090008672000-1938500003335260000-22987000-67000164630000010019000-2265000066560000-2721020000848530003140400015248500002043100002433260000-6967800096775800000019223700007755210000000000094251000292476000000000000000000000839170000-157895000-27220300000139810000000003347320002170700053616000517760000-213000-44806300055255000-195000053305000238167000291472000Remeasurement of the Defined Benefit Liabilities/ (Asset)476000Income tax relating to items that will not be reclassified to profit or loss-119000357000Remeasurement of the Defined Benefit Liabilities/ (Asset)-797000Income tax relating to items that will not be reclassified to profit or loss201000-59600000Exchange differences in translating the Financial Statements of Foreign Operations-67042000Income tax relating to items that will be reclassified to profit or loss16873000-50169000Exchange differences in translating the Financial Statements of Foreign Operations12435000Income tax relating to items that will be reclassified to profit or loss-3130000930500000-498120008709000